Phase II study of alemtuzumab (CAMPATH-1®) in patients with HTLV-1-associated adult T-cell leukemia/lymphoma

PURPOSE: Therapeutic regimens for ATL are limited with unsatisfactory results, thereby warranting development of novel therapies. This study investigated antitumor activity and toxicity of alemtuzumab with regard to response, duration of response, progression free survival, and overall survival in p...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Clin Cancer Res
Main Authors: Sharma, Kamal, Janik, John E., O’Mahony, Deirdre, Stewart, Donn, Pittaluga, Stefania, Stetler-Stevenson, Maryalice, Jaffe, Elaine S., Raffeld, Mark, Fleisher, Thomas A., Lee, Cathryn C., Steinberg, Seth M., Waldmann, Thomas A., Morris, John C.
Format: Artigo
Sprog:Inglês
Udgivet: 2016
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5215752/
https://ncbi.nlm.nih.gov/pubmed/27486175
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-16-1022
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker